Precision Health

In an early Stanford Medicine study, CAR-T cell therapy helps some with intractable lymphoma, but those who relapse have few options. Modifying the therapy’s molecular target improved response.

The artificial intelligence technology can be trained by pathologists, giving them personalized assistance in identifying cells that might indicate diseases such as cancer or endometritis.

Stanford Medicine researchers and their colleagues tracked the gut, mouth, nose and skin bacteria of 86 people for as long as six years to try to gauge what constitutes a healthy microbiome.

Stanford Medicine researchers have developed a powerful new artificial intelligence model that can distinguish between male and female brains.

The award will facilitate a clinical trial testing the safety of CAR-T cells — immune cells from patients’ own bodies that have been bioengineered to destroy cancer cells — used to treat a deadly brain cancer.

New technology combines radiotherapy with real-time detection of cancer cells to target moving tumors or multiple metastases. Stanford Medicine is the first to research the technology in the clinic.

Previous large health studies didn’t collect sexual orientation and gender identity information. A Stanford Medicine study finds the All of Us Research Program a boon to LGBTQ health researchers, future health outcomes.

Stanford Medicine researchers find that using in vitro fertilization with testing embryos for inherited diseases would significantly reduce costs.

Using surveys, cognitive tests and brain imaging, researchers have identified a type of depression that affects about a quarter of patients. The goal is to diagnose and treat the condition more precisely.

The Stanford Medicine psychiatrist was an expert in the development of psychopathologies and a beloved mentor to many.

The new issue of Stanford Medicine magazine features articles about the molecules that make us who we are and how understanding them can lead to medical discoveries and innovations.